Alessandra Fusco (2017) “Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience”, Heart Research, 4(3), pp. 46–56. doi: 10.17140/HROJ-4-141.